Literature DB >> 33791368

Research Achievements of Oral Submucous Fibrosis: Progress and Prospect.

Hui Xu1,2,3, Feng-Yuan Lyu2,3,4, Jiang-Yuan Song1,2,3, Yu-Ming Xu5, Er-Hui Jiang5, Zheng-Jun Shang5, Li-Li Chen1,2,3, Zhi Xu1,2,3.   

Abstract

Oral submucous fibrosis (OSMF) is a kind of chronic, insidious disease, and it is categorized into potentially malignant disorders (PMD), which poses a global and regional problem to public health. It is considered to be a multifactorial disease, such as due to areca nut chewing, trace element disorders, and genetic susceptibility. However, there is still no unanimous conclusion on its pathogenesis, diagnosis, and treatment strategies. Hence, this article provides a comprehensive review and prospect of OSMF research, providing scholars and clinicians with a better perspective and new ideas for the research and treatment of OSMF.
Copyright © 2021 Hui Xu et al.

Entities:  

Mesh：

Year:  2021        PMID： 33791368      PMCID： PMC7997751          DOI： 10.1155/2021/6631856

Source DB:  PubMed          Journal:  Biomed Res Int            Impact factor:   3.411


  95 in total

Review 1.  Proposed clinical classification for oral submucous fibrosis.

Authors:  Chandramani B More; Sunanda Das; Hetul Patel; Chhaya Adalja; Vaishnavee Kamatchi; Rashmi Venkatesh
Journal:  Oral Oncol       Date:  2011-11-08       Impact factor: 5.337

2.  Evaluation of the possible role of copper ions in drinking water in the pathogenesis of oral submucous fibrosis: a pilot study.

Authors:  Gururaj Arakeri; Shekhar Gowda Patil; D N S V Ramesh; Santosh Hunasgi; Peter A Brennan
Journal:  Br J Oral Maxillofac Surg       Date:  2013-02-20       Impact factor: 1.651

3.  Oral submucous fibrosis--a new treatment regimen.

Authors:  D Gupta; S C Sharma
Journal:  J Oral Maxillofac Surg       Date:  1988-10       Impact factor: 1.895

4.  Oral submucous fibrosis.

Authors:  J J Pindborg; S M Sirsat
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1966-12

5.  Extracellular matrix remodeling in oral submucous fibrosis: its stage-specific modes revealed by immunohistochemistry and in situ hybridization.

Authors:  Hiroko Utsunomiya; Wanninayake M Tilakaratne; Kazufumi Oshiro; Satoshi Maruyama; Makoto Suzuki; Hiroko Ida-Yonemochi; Jun Cheng; Takashi Saku
Journal:  J Oral Pathol Med       Date:  2005-09       Impact factor: 4.253

6.  Betel-quid and oral submucous fibrosis: a cross-sectional study in Hunan province, China.

Authors:  Shan-Shan Zhang; Wen-Hui Li; Yi-Jun Gao; Zhi-Wen Liu; Lin Liu; Jie-Qing Tang; Tian-You Ling
Journal:  J Oral Pathol Med       Date:  2012-05-19       Impact factor: 4.253

Review 7.  Oral submucous fibrosis: etiology, pathogenesis, and future research.

Authors:  R Rajendran
Journal:  Bull World Health Organ       Date:  1994       Impact factor: 9.408

8.  Modification of in vivo and in vitro TNF-alpha, IL-1, and IL-6 secretion by circulating monocytes during hyperbaric oxygen treatment in patients with perianal Crohn's disease.

Authors:  G Weisz; A Lavy; Y Adir; Y Melamed; D Rubin; S Eidelman; S Pollack
Journal:  J Clin Immunol       Date:  1997-03       Impact factor: 8.317

Review 9.  Stem cell therapy: A novel treatment approach for oral mucosal lesions.

Authors:  G N Suma; Madhu Pruthi Arora; Manisha Lakhanpal
Journal:  J Pharm Bioallied Sci       Date:  2015 Jan-Mar

10.  Efficacy of oral colchicine with intralesional hyaluronidase or triamcinolone acetonide in the Grade II oral submucous fibrosis.

Authors:  Dipti Daga; R K Singh; U S Pal; Tikaram Gurung; Shilpi Gangwar
Journal:  Natl J Maxillofac Surg       Date:  2017 Jan-Jun
View more
  1 in total

Review 1.  Single-cell RNA sequencing in oral science: Current awareness and perspectives.

Authors:  Jie Wu; Yumei Ding; Jinyu Wang; Fengyuan Lyu; Qingming Tang; Jiangyuan Song; Zhiqiang Luo; Qian Wan; Xiaoli Lan; Zhi Xu; Lili Chen
Journal:  Cell Prolif       Date:  2022-07-17       Impact factor: 8.755
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.